This site is intended for Healthcare professionals only.

Marksans Pharma gets EIR from USFDA for its Goa facility


Marksans Pharma gets EIR from USFDA for its Goa facility

New Delhi: Drug firm Marksans Pharma said it has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility.

The company has received EIR from the United States Food and Drug Administration (USFDA) after inspection of its Goa facility from April 3-7, 2017, Marksans Pharma said in a BSE filing.

As per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.



Source: PTI
0 comment(s) on Marksans Pharma gets EIR from USFDA for its Goa facility

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted